Grifols

GRFS

0 Urmăritori

$7.10

-2.74%

-$0.20

Urmărește

12 Mai

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

GRFS Fair Price

$5.27

Undervalued by 70.3%

Pentru a afișa prețul corect al unei acțiuni, trebuie să fiți membru Bulios Black.

My Notes

Začít psát

Profile

Grifols, S.A. is a global Spanish pharmaceutical and biotechnology company specializing in the production of plasma-derived medicines and healthcare products. The company focuses on producing immunoglobulins, albumin, and other plasma-based products that are essential for the treatment of various diseases, including immunological and neurological disorders. Grifols also develops diagnostic tools and systems for hospitals and clinics. The company has a broad global presence and operates in over 30 countries worldwide.

Feed

There are no posts to show right now.